Metraipolis › archive › dc_b0b2b159fb7d
Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study — Europe PMC PMID:41306981
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41306981
- DOI
- 10.3389/fimmu.2025.1671251
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:02:20.378Z
- SHA-256 of the archived text
a2bb2563b6668c5e1566c76a3dee0e514697e68e8da357a2f3af5acaabba7f20- Stable URL of this page
https://metraipolis.com/documento/dc_b0b2b159fb7d
How to cite
Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study — Europe PMC PMID:41306981 — Europe PMC (en), https://europepmc.org/article/MED/41306981 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b0b2b159fb7d (Metraipolis archive dc_b0b2b159fb7d, sha256 a2bb2563b6668c5e1566c76a3dee0e514697e68e8da357a2f3af5acaabba7f20)
BibTeX
@misc{dcb0b2b159fb7d,
title = {Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study — Europe PMC PMID:41306981},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41306981},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b0b2b159fb7d; sha256 a2bb2563b6668c5e1566c76a3dee0e514697e68e8da357a2f3af5acaabba7f20},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41306981. Agents can read the archived copy with the MCP tool read_document.